Flagchem(SZ:300575)2023-04-26 16:00Financial Performance - The company's revenue for Q1 2023 was ¥742,208,239.27, representing a 6.48% increase compared to ¥697,011,849.26 in the same period last year[5]. - Net profit attributable to shareholders decreased by 14.55% to ¥92,697,364.92 from ¥108,487,534.29 year-on-year[5]. - Basic and diluted earnings per share fell by 14.29% to ¥0.30 from ¥0.35 in the same period last year[5]. - The net profit for Q1 2023 was CNY 93,087,695.73, a decrease of 15.1% compared to CNY 109,569,267.39 in Q1 2022[25]. - Operating profit for Q1 2023 was CNY 109,113,760.34, down from CNY 123,305,135.09 in the same period last year, reflecting a decline of 11.5%[25]. - The total comprehensive income for Q1 2023 was CNY 93,087,695.73, compared to CNY 109,569,267.39 in the previous year[26]. Cash Flow - The net cash flow from operating activities was negative at -¥12,813,236.69, a significant decline of 110.08% compared to ¥127,163,675.68 in the previous year[5][10]. - Cash flow from operating activities showed a net outflow of CNY 12,813,236.69, contrasting with a net inflow of CNY 127,163,675.68 in the previous year[28]. - Cash flow from financing activities generated a net inflow of CNY 324,685,685.02, significantly higher than CNY 106,322,590.51 in the same quarter last year[29]. - Investment activities resulted in a net cash outflow of CNY 117,018,363.95, compared to a net outflow of CNY 185,607,382.13 in Q1 2022[29]. Assets and Liabilities - Total assets increased by 5.68% to ¥4,269,788,983.74 from ¥4,040,204,603.89 at the end of the previous year[5]. - Total liabilities increased to CNY 2,112,373,400.55, up from CNY 1,983,685,733.84, representing a growth of 6.5%[22]. - The company’s non-current liabilities totaled CNY 872,868,578.27, an increase of 17.3% from CNY 744,546,303.71 at the beginning of the year[22]. Research and Development - The company reported a 51.21% increase in R&D expenses, amounting to ¥20,035,005.50 compared to ¥13,250,073.15 in the previous year[9]. - Research and development expenses for Q1 2023 were CNY 20,035,005.50, an increase of 51.1% compared to CNY 13,250,073.15 in Q1 2022, highlighting a focus on innovation[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 11,284[12]. - The largest shareholder, Wu Yaojun, holds 28.84% of shares, totaling 89,407,395 shares, with 22,050,000 shares pledged[12]. - The second-largest shareholder, Zhang Ji, holds 5.75% of shares, totaling 17,820,000 shares[12]. - The top ten shareholders collectively hold significant stakes, with the largest institutional investor being Jiashi Fund Management, holding 3.16%[12]. - Wu Yaojun and Zhang Ji are identified as the controlling shareholders and are related as spouses[14]. - The company has a total of 85,537,496 restricted shares at the end of the reporting period[17]. Operational Insights - The total operating revenue for Q1 2023 was CNY 742,208,239.27, an increase of 6.4% compared to CNY 697,011,849.26 in the same period last year[24]. - The total operating costs for Q1 2023 amounted to CNY 627,860,768.96, up 11.0% from CNY 565,531,801.94 in Q1 2022[24]. - The operating profit margin decreased due to increased costs, with operating costs representing approximately 84.6% of total revenue in Q1 2023 compared to 81.2% in Q1 2022[24]. - The company transferred 100% equity of its wholly-owned subsidiary for CNY 11.6 million to a controlling subsidiary, indicating strategic restructuring[18]. - The company did not report any significant new product developments or market expansions during this quarter[30].